Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05838690 · ClinicalTrials.gov registry record · NA
Optimizing Tracheal Intubation Outcomes and Neonatal Safety
A NA study of Intubation Complication and Infant, sponsored by Children's Hospital of Philadelphia.
- Recruiting
- Registry status
- NA
- Development phase
- 3,000
- Enrollment target
- 8
- Study locations
NCT05838690: Recruiting NA study of Intubation Complication and Infant, sponsored by Children's Hospital of Philadelphia.
NCT05838690 is a NA study of Intubation Complication and Infant that is actively recruiting participants, run by Children's Hospital of Philadelphia. The registered enrollment target is 3,000 participants, below the 26,253-participant average among 10 other Intubation Complication trials with a reported enrollment target (89% lower). The trial reports 8 study locations across 8 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05838690, a NA study of Intubation Complication and Infant, is actively recruiting participants, sponsored by Children's Hospital of Philadelphia.
- RECRUITING
- Registry status
- NA
- Development phase
- 3,000 participants
- Enrollment target
- 8
- Study locations
Study Summary
The purpose of the study is to assess the impact of a personalized intubation planning tool, the Personalized INtubation Safety (PINS) Bundle on intubation procedural safety and clinical outcomes among patients intubated in the neonatal intensive care unit (NICU) setting.
Primary Outcome
Any adverse tracheal intubation associated event (TIAE) during the intubation encounter. In NEAR4NEOS database, a comprehensive group of adverse TIAEs are based on standard consensus-based definitions and classified as severe and non-severe
Conditions Studied
Interventions
- OTHER Personalized Intubation Safety (PINS) Bundle
Study Locations (8)
Arkansas
- University of Arkansas Medical Sciences - Little Rock
Colorado
- University of Colorado - Denver - Denver
Connecticut
- Yale-New Haven Hospital - New Haven
New Hampshire
- Dartmouth-Hitchcock Clinic - Lebanon
North Carolina
- WakeMed Health & Hospitals - Raleigh
Pennsylvania
- Penn State Milton S. Hershey Medical Center - Hershey
Washington
- University of Washington - Seattle
Quebec
- CHU Sainte-Justine - Montreal
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 3,000 participants |
| Start Date | 2023-04-01 |
| Est. Completion | 2027-12-31 |
| Phase | NA |
What NCT05838690 shows while recruiting
NCT05838690 is an interventional study that assigns participants to a tested intervention. Its 3,000 participants enrollment target places it among the larger protocols in the corpus, below the 26,253-participant average among 10 other Intubation Complication trials with a reported enrollment target (89% lower).
The record links to 2 conditions, with Intubation Complication appearing as the primary indexed condition, and to 1 intervention - of which Personalized Intubation Safety (PINS) Bundle is the first listed.
NCT05838690 lists 8 locations in 8 states (Arkansas, Colorado, Connecticut).
Frequently Asked Questions
What is clinical trial NCT05838690 about?
NCT05838690 is a clinical study titled "Optimizing Tracheal Intubation Outcomes and Neonatal Safety". The purpose of the study is to assess the impact of a personalized intubation planning tool, the Personalized INtubation Safety (PINS) Bundle on intubation procedural safety and clinical outcomes among patients intubated in the neonatal intensive care unit (NICU) setting.
What is the current status of trial NCT05838690?
This trial is currently recruiting. It is a NA study. The enrollment target is 3,000 participants. The study started on 2023-04-01. Estimated completion is 2027-12-31.
What conditions does trial NCT05838690 study?
This clinical trial studies the following conditions: Intubation Complication, Infant.
What interventions are being tested in trial NCT05838690?
The interventions under investigation include: Personalized Intubation Safety (PINS) Bundle (OTHER).
Who is sponsoring clinical trial NCT05838690?
This trial is sponsored by Children's Hospital of Philadelphia, which has 431 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05838690 being conducted?
This trial has 8 study locations across Arkansas, Colorado, Connecticut, New Hampshire, North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Intubation Complication
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05838690's enrollment target sits among peer trials
3,000 4th of 10 higher than 6 of 10 other Intubation Complication trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Intubation Complication trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Sonographic Assessment of Cricoid Pressure
RECRUITING · NA
-
The ED-AWARENESS-2 Trial
RECRUITING · NA
-
Smart Checklist Implementation for Pediatric Tracheal Intubations in the ICU- Multicenter Study
RECRUITING · NA
-
Nasotracheal Intubation With VL vs DL in Infants Trial
COMPLETED · NA
-
CRICKET: Critical Events in Anaesthetised Kids Undergoing Tracheal Intubation
RECRUITING
-
InfasurfAero™ Versus Sham Treatment in Preterm Newborns With RDS
RECRUITING · Phase 3
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00004847 · 3,000 participants · Phase 1
Diagnosis of Pheochromocytoma
- NCT00478712 · 3,000 participants
Hirschsprung Disease Genetic Study
- NCT00579566 · 3,000 participants
Novel Biochemical and Molecular Determinants for Soft Tissue Sarcoma
- NCT00816114 · 3,000 participants
Chart Review Study of Chronic Myelogenous Leukemia (CML) Patients Treated With Imatinib Outside of a Clinical Trial
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI